Anti Inhibitor Coagulant Complex + Emicizumab Interaction
Unknowninteraction on record
Description
No adequate and well-controlled studies of the combined or sequential use of FEIBA and recombinant factor VIIa antifibrinolytics, or emicizumab have been conducted. Clinical experience from an emicizumab clinical trial suggests that a potential drug interaction may exist with emicizumab when FEIBA was used as part of a treatment regimen for breakthrough bleeding 6 [see Warnings and Precautions (5.1) ] .
Source: FDA drug label - anti-inhibitor coagulant complex